Atom | Systematic Testing of Radionuclides in Preclinical Experiments (STRIPE) (R01 Clinical Trial Not Allowed)

Due Dates: February 5, 2025 (New) | March 5, 2025 (Renewal/Resubmission/Revision)

Funding Amounts: Up to $500,000 direct costs per year, for up to 5 years (R01 mechanism)

Summary: Supports preclinical research on the biological effects of different radiation types used in radionuclide-based cancer therapeutics, excluding clinical trials.

Key Information: Clinical trials are not allowed; applications must include experimental testing of radionuclide-based agents.

Systematic Testing of Radionuclides in Preclinical Experiments (STRIPE) (R01 Clinical Trial Not Allowed)

Sign in to see full grant listing